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https://doi.org/10.1016/j.stemcr.2019.10.006SUMMARYWith extended stays aboard the International Space Station (ISS) becoming commonplace, there is a need to better understand the
effects of microgravity on cardiac function. We utilized human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
to study the effects of microgravity on cell-level cardiac function and gene expression. The hiPSC-CMs were cultured aboard the
ISS for 5.5 weeks and their gene expression, structure, and functions were compared with ground control hiPSC-CMs. Exposure to
microgravity on the ISS caused alterations in hiPSC-CM calcium handling. RNA-sequencing analysis demonstrated that 2,635 genes
were differentially expressed among flight, post-flight, and ground control samples, including genes involved in mitochondrial meta-
bolism. This study represents the first use of hiPSC technology to model the effects of spaceflight on human cardiomyocyte structure
and function.INTRODUCTION
The allure of space as a natural laboratory stems from its
unique properties that cannot be perfectly duplicated on
Earth, notably microgravity, which has been simulated us-
ing techniques such as rotating bioreactors, random posi-
tioning machines, and magnetic levitation (Becker and
Souza, 2013). While spaceflight is largely government
funded, private enterprises dedicated to low-orbit payload
delivery have enabled space to become a realistic destina-
tion for science (Rogers, 2001). However, the effects of
microgravity on human organ function must be better un-
derstood. Because of the heart’s critical role in maintaining
proper bodily systemic functions, the effects of micro-
gravity on cardiac physiology, metabolism, and cellular
biology should be elucidated.
Spaceflight induces physiological changes in cardiac
function (Sides et al., 2005). Astronauts on space shuttle
missions experienced reduced heart rate and lowered arte-
rial pressure (Fritsch-Yelle et al., 1996; Perhonen et al.,
2001). The National Aeronautics and Space Administra-
tion (NASA) Twin Study demonstrated that long-term
exposure to microgravity reduces mean arterial pressure
and increases cardiac output (Garrett-Bakelman et al.,960 Stem Cell Reports j Vol. 13 j 960–969 j December 10, 2019 j ª 2019 Th
This is an open access article under the CC BY-NC-ND license (http://creativ2019). However, little is known about the role of
microgravity in influencing human cardiac function at
the cellular level.
Existing cardiac cellular microgravity studies have used
mouse or rat cardiomyocyte (CM) models. Alterations
occur in mRNA expression of rat cardiac myosin protein,
critical for CM contractility, when animals are maintained
in microgravity (Thomason et al., 1992). Microgravity up-
regulates the expression of mitochondrial metabolism
genes, such as malate dehydrogenase, in rat cardiac muscle
(Connor and Hood, 1998). Hindlimb suspension of rats
promoted the expression of a unique isoform of cardiac
troponin I, critical for proper CM contraction (Yu et al.,
2001). In rat CMs, simulated microgravity altered nuclear
localization of nuclear factor kB, which is implicated in
the cellular response to oxidative stress (Kwon et al.,
2009). However, animal models cannot perfectly replicate
cellular functions in human cardiac tissues, partly due to
species-specific differences in cardiac function (Fermini
et al., 1992; Gauthier et al., 1999; Spotnitz et al., 1984).
Thus, we should understand the cellular and physiological
processes influenced by microgravity in human heart cells.
Human CMs are a limited resource and cannot be
maintained long term (Bergmann et al., 2009). However,e Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Evaluating the Effects of Spaceflight on hiPSC-CM Structure and Function
(A) Timeline for experiment. Tissue samples were collected from three individuals and used to generate human induced pluripotent stem
cell-derived cardiomyocytes (hiPSC-CMs). The hiPSC-CMs were plated in fully enclosed 6-well plates optimized for microgravity (‘‘BioCells’’)
and sent to the International Space Station (ISS) for culture and live imaging for1 month. Ground controls with the same hiPSC-CM lines
and hardware were maintained at Stanford University. Media exchanges and imaging were strictly scheduled so that the only significant
difference in cell environment was spaceflight. After sample return from the ISS, cellular phenotypes were evaluated using gene
expression, immunofluorescence, calcium imaging, and contractility analyses.
(B) A BioCell in its environmental control habitat (‘‘PHAB’’).
(C) The interior of the Space Automated Bioproduct Laboratory (SABL), the incubator used to maintain the cells on the ISS.human induced pluripotent stem cell-derived CMs
(hiPSC-CMs) have emerged as a surrogate for studying
the molecular and cellular mechanisms of human car-
diac pathophysiology (Sharma et al., 2013, 2017, 2018;
Sun et al., 2012). The hiPSC-CMs can be mass produced,
cultured long term, and manipulated in vitro (Sharma
et al., 2013). Employing a multi-disciplinary approach
and access to the International Space Station (ISS), we
utilized hiPSC-CMs to provide insights into the effects
of spaceflight and microgravity on human cardiac phys-
iology, cell structure, and gene expression.RESULTS
Microgravity Cell Culture and Maintenance of hiPSC-
CMs in Space
hiPSC lines were generated from three individuals by
reprogramming peripheral blood mononuclear cells
(PBMCs) and differentiating them into hiPSC-CMs
(Burridge et al., 2014). Monolayers of beating hiPSC-
CMs were sent to the ISS for 5.5 weeks (Figure 1A). The
hiPSC-CMs were grown in fully enclosed 6-well plates
(BioCells) optimized for long-termmicrogravity cell cultureStem Cell Reports j Vol. 13 j 960–969 j December 10, 2019 961
(Figure 1B). BioCells were launched to the ISS aboard a
SpaceX Dragon transport spacecraft via a SpaceX Falcon 9
rocket during the SpaceX CRS-9 commercial resupply ser-
vice mission. BioCells were maintained aboard the ISS in
an on-station incubator (Space Automated Bioproduct Lab-
oratory [SABL]) (Figure 1C) at 37C and 5% CO2, and
ground control cells were cultured in parallel. The hiPSC-
CMs within the BioCells were cultured in a high-nutrient
CM maintenance medium that was changed weekly.
Ground control hiPSC-CMs were maintained identically,
with media changes replicated exactly on a 6-h delay
from the ISS.
Functional Analyses of hiPSC-CMs in Microgravity
Conditions and Post Spaceflight
Prolonged spaceflight alters human heart physiology.
Thus, we aimed to determine the effects of microgravity
on hiPSC-CM morphology and function. Upon return
to Earth, space-flown hiPSC-CMs were evaluated for
changes in morphology and structure. Phase-contrast mi-
croscopy found no overt changes between groundside
controls and flight samples (Figure 2A). The hiPSC-CMs
from cell line 2 exhibited lower cell confluence than
other lines, likely due to lower survival at initial plating.
Immunofluorescence of ground and flight samples
for sarcomeric proteins a-actinin and cardiac troponin T
(cTnT) illustrated standard, striated sarcomeres (Fig-
ure 2B). DAPI-positive and cTnT/a-actinin-negative cells
indicated the presence of a non-myocyte, fibroblast-like
population. We did not observe significant differences
in sarcomere structure, length, or regularity between
ground and flight samples (Figures 2C–2E). These results
suggest that space-flown hiPSC-CMs retain sarcomeric
structure and morphology when compared with ground
hiPSC-CMs.
For hiPSC-CM functional assessment, we analyzed
hiPSC-CM contractile properties using video microscopy
(Videos S1 and S2) with motion vector analysis (Huebsch
et al., 2015). Ground and space-flown hiPSC-CMs had a
similar spontaneous beat rate after 2.5 weeks (Figure 3A).
There was no significant difference between contraction
and relaxation velocities (Figures 3B and 3C). We also
assessed Ca2+-handling properties of space-flown hiPSC-
CMs after return to Earth (Figure 3D). Space-flown hiPSC-
CMs exhibited unchanged Ca2+ transient amplitude but
showed a significant increase in transient decay tau (Fig-
ures 3E and S1) that is indicative of a decreased calcium re-
cycling rate. We also observed an increase in the standard
deviation of beating intervals (Figure 3F) in space-flown
hiPSC-CMs, indicating beating irregularity. These results
suggest that calcium-handling-related parameters remain
altered for space-flown hiPSC-CMs following return to
normal gravity.962 Stem Cell Reports j Vol. 13 j 960–969 j December 10, 2019Gene Expression of hiPSC-CMs in Microgravity and
Post Spaceflight
We analyzed the transcriptome of hiPSC-CMs during
spaceflight and post-flight. hiPSC-CMs were harvested at
4.5 weeks in spaceflight and on day 10 after return to Earth.
Ground hiPSC-CMs were collected at the post-return time
point as controls. Based on RNA sequencing, principal
component analyses of flight, post-flight, and ground
hiPSC-CMs showed that samples clustered based on the
cell line of origin (Figure S2A) and developed a differential
pattern of gene expression during the experiment. Flight
samples clustered separately from post-flight samples,
which in turn clustered most closely with ground controls
(Figure 4A).
Based on our contractility and calcium-handling data, we
examined expression of genes related to these functions.
There was no significant change in expression levels of cal-
cium cycling-related genes ryanodine receptor 2 (RYR2) or
sarcoplasmic/ER calcium ATPase 2 (SERCA2) (Figure 4B).
Thus, the declined calcium recycling we observed may
have resulted from stress-induced calcium sarcoplasmic re-
ticulum (SR) load increase, shifting the calcium balance be-
tween the SR and cytoplasm and decreasing the recycling
rate through the same amount of SERCA2a. Increased SR
load may increase calcium leak from RyR2, which would
promote the beating irregularity we observed.
Sarcomeric genes cardiac troponin T (TNNT2) and
troponin I1 (TNNI1) were significantly upregulated in
flight, although other sarcomeric genes were similarly ex-
pressed (MYH7). Motif enrichment analysis of differen-
tially expressed genes among the conditions (Table S2)
indicated that the motif for specificity protein 1 (Sp1) was
enriched for genes upregulated in flight compared with
ground. Sp1 activates the TNNT2 promoter, which can
contribute to a hypertrophic phenotype (Azakie et al.,
2006).
Myocyte enhancer factor 2 (MEF2) transcription factor
motifs were enriched in genes upregulated in flight
comparedwith ground. Like Sp1, MEF2 contributes to regu-
lation of a hypertrophic phenotype (Agrawal et al., 2010).
MEF2D, whichmediates stress-dependent cardiac remodel-
ing (Kim et al., 2008), was upregulated in flight hiPSC-CMs
compared with that on the ground (Figure 4C). Association
of MEF2 with class II histone deacetylases (HDACs) re-
presses hypertrophy, whereas class I HDACs induce hyper-
trophy (Agrawal et al., 2010). Expression of HDAC10 and
HDAC4 (class II) was lower in flight hiPSC-CMs than on
the ground, whereas expression of HDAC8 (class I) was
increased.
Other transcription factors for which motifs were en-
riched include peroxisome proliferator-activated receptors,
Kru¨ppel-like factor 5 (KLF5), and chicken ovalbumin up-
stream promoter transcription factor II (COUP-TFII), which
(legend on next page)
Stem Cell Reports j Vol. 13 j 960–969 j December 10, 2019 963
are involved in regulating cardiac metabolism (Drosatos
et al., 2016; Wu et al., 2015). Although expression of these
factors was not significantly different among the three con-
ditions (Figure 4D), further annotation of RNA-sequencing
data revealed that genes belonging to the mitochondrial
metabolic pathway showed the most significant changes
both between flight and ground and between flight and
post-flight (Figures 4E and S2B; Table S3). Flight samples
showed a decreased expression of genes related to RNA/
DNA helicase and DNA damage and repair compared
with both post-flight and ground samples. The numbers
of differentially expressed genes in a two-group compari-
son between ground and flight (3,008 genes) and between
post-flight and flight (2,026 genes) were much greater than
the number of differentially expressed genes between post-
flight and ground (1,049 genes), with the most overlap in
differentially expressed genes between the ground versus
flight and post-flight versus flight comparisons (Figure 4F).
These results suggest that hiPSC-CMs adopt a unique gene-
expression signature during spaceflight, and this gene-
expression pattern reverts to one similar to ground controls
upon return to normal gravity.DISCUSSION
Decades of observations on space-flown animal models
and human astronauts have confirmed that cardiovascular
physiology is profoundly changed by spaceflight (Hughson
et al., 2017). However, most cardiovascular microgravity
physiology studies have been conducted either in non-hu-
man models or at tissue, organ, or systemic levels. While
recent studies of human cardiac progenitor cells have
demonstrated that microgravity can enhance their differ-
entiation and maintenance (Baio et al., 2018; Camberos
et al., 2019; Jha et al., 2016), none have addressed the ef-
fects of spaceflight on differentiated cardiomyocytes. Using
6-well plates optimized for microgravity, we sent live
hiPSC-CMs from three individuals to the ISS as an in vitro
human model for microgravity exposure.
Previous microgravity studies in animal models have
demonstrated changes in contractile muscle protein
expression (Thomason et al., 1992; Yu et al., 2001). While
we did not observe a significant difference in contractilityFigure 2. hiPSC-CMs Demonstrate No Overt Changes in Cell Morph
(A) Representative phase-contrast images of live-return hiPSC-CMs fr
paraformaldehyde fixation.
(B) Immunofluorescence of flight and ground control samples from ea
and a-actinin, and nuclear stain DAPI. Scale bars represent 50 mm.
(C–E) Pearson’s coefficient (C), period (D), and fast Fourier transform
ground and flight samples (arbitrary units). N = 3 lines, n = 2–3 imag
Error bars represent standard error of the mean (SEM).
964 Stem Cell Reports j Vol. 13 j 960–969 j December 10, 2019or differences in cellmorphology or sarcomere structure be-
tween space-flown and groundside CMs, we did observe
changes in calcium recycling and expression of myofila-
ment genes in space-flown hiPSC-CMs. These findings
parallel the aforementioned organ-level observations and
suggest that, even at the cellular level, human CMs can
functionally respond to changes in apparent gravity.
Gene-expression pathways related to mitochondrial
function were upregulated in space-flown hiPSC-CMs.
Binding motifs for transcription factors known to regulate
cardiac metabolism were enriched in space-flown hiPSC-
CMs. These results align with previous studies showing
that the rat heart undergoes mitochondrial adaptations
via gene upregulation after short-term exposure to micro-
gravity (Connor and Hood, 1998). The NASA Twin Study
also noted mitochondrial-related gene-expression changes
(Garrett-Bakelman et al., 2019). Although their analysis
was performed in PBMCs, the presence of mitochondrial
gene-expression changes in their study and ours indicates
that a cellular-level response to spaceflight may not be
cell-type specific. Annotation of genes upregulated in
post-flight compared with ground indicated that mito-
chondrial pathways were still enriched, demonstrating
that a return to normal gravity does not completely restore
normal mitochondrial gene expression, at least not within
the first 10 days after return. Motif enrichment analysis
also demonstrated that motifs enriched in genes upregu-
lated in space-flown hiPSC-CMs were associated with tran-
scription factors known to regulate hypertrophic pathways.
While we identified mitochondria- and hypertrophy-
related pathways as those of interest, our conclusions are
limited by time scale and available methods for this study.
Longer exposure to microgravity or a longer readjustment
period to normal gravity may change the extent of irrevers-
ible and reversed gene-expression changes, respectively.
Additionally, the flight RNA samples were preserved at a
different time points than the post-flight and ground sam-
ples, which may have contributed to the observed differ-
ences in gene expression. Finally, while we matched media
change timing and environmental conditions for ground
and flight samples as closely as possible, we note additional
variables. For example, radiation levels are higher aboard
the ISS than on Earth. Also, flight samples experienced
launch and re-entry, whereas ground samples did not.ology or Sarcomere Structure after Return from Spaceflight
om each cell line 3 days after sample return from the ISS, prior to
ch cell line showing sarcomeric proteins cardiac troponin T (cTnT)
(E) power of cTnT and a-actinin signals along sarcomere lines for
es per line, with 8–15 sarcomeres analyzed per image.
Figure 3. hiPSC-CM Contraction and Calcium Handling Are Altered by Spaceflight
(A–C) Beat rate in beats per minute (bpm) (A), contraction velocity (B), and relaxation velocity (C) for ground control and flight hiPSC-CMs
after 1.5 and 2.5 weeks of culture on the ISS. N = 3 lines, n = 1–2 biological replicates per line, with 1–4 videos per sample.
(D) Representative calcium transients for ground and flight conditions, measured 3 days after live return from the ISS.
(E and F) Transient decay tau (E) and standard deviation of beating intervals (F) from calcium transients. N = 103 and 34 cells in ground
and flight groups, respectively. **p < 0.01 and ***p < 0.001 versus ground control.
Error bars represent SEM. See also Figure S1; Videos S1 and S2.The forces that cells experienced during transit may have
affected their phenotype and gene expression. In future
studies, including a 1G centrifuge control on the ISS or a
simulated microgravity control on the ground may help
disaggregate these effects.
There are also well-established caveats to using hiPSC-
CMs. We noted the presence of non-cardiomyocyte,fibroblast-like cells in each hiPSC-CM line, likely due to
incomplete metabolic selection of hiPSC-CMs prior to
spaceflight. Perfect purification of hiPSC-CMs remains an
issue during differentiation, and long-termmetabolic selec-
tion using a low-glucose medium is often unable to
completely eliminate fibroblasts. Residual fibroblasts may
have proliferated during this month-long experiment.Stem Cell Reports j Vol. 13 j 960–969 j December 10, 2019 965
(legend on next page)
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Additionally, hiPSC-CMs typically exhibit an immature
human cardiac phenotype that is reflected in the contrac-
tility, force output, electrophysiology, and overall structure
of these cells, all of which differ from true adult human
CMs (Oikonomopoulos et al., 2018). However, we still
believe that hiPSC-CMs represent the best model currently
available for studying cell-level human cardiac function in
response to environmental stimuli such as microgravity.
Further investigations into cardiac response to space-
flight are necessary to confirm these results and elucidate
the mechanism of response to microgravity. Studies of
functional changes in mitochondria of CMs exposed to
microgravity would complement the gene-expression
changes we observed. Using three-dimensional, tissue-like
structures, such as engineered heart tissues or cardiac orga-
noids, would provide a more physiologically accurate
model and allow study of interactions between multiple
cell types (Wnorowski et al., 2019). Eventually, these plat-
forms may enable prevention or treatment strategies to
be developed for spaceflight-induced cardiac remodeling.
Our study demonstrated for the first time that hiPSC-
CMs can model the effects of spaceflight and microgravity.
Human heart muscle cells, like the whole heart, change
their functional properties in spaceflight and compensate
for the apparent loss of gravity by altering their gene-
expression patterns at the cellular level. As humans spend
more time in space, we must better understand the effects
of spaceflight on human physiology at the cellular level.
Here, we demonstrated that long-term cell culture of
advanced, highly specialized cell types such as human
CMs is possible aboard the ISS and that such studies can
provide informative data. We also laid the groundwork
for future studies that will employ next-generation tech-
nologies, such as three-dimensional organoids, organ or
body-on-a-chip systems, and high-throughput screening
platforms, to more accurately model cardiac and human
physiology in spaceflight.EXPERIMENTAL PROCEDURES
Full details are provided in Supplemental Experimental
Procedures.Figure 4. hiPSC-CM RNA Expression Profiles Are Altered by Space
RNA-sequencing data comparing flight samples preserved in RNAlate
10 days post return after 5.5 weeks in microgravity, and ground co
(A) Heatmap displaying 2,635 genes differentially expressed among
(B–D) Expression of genes related to (B) calcium handling and contr
(E) Group enrichment scores for top functional annotation clusters (e
Database for Annotation, Visualization, and Integrated Discovery (DAV
with p% 0.05 based on a two-tailed Student’s t test.
(F) Venn diagram demonstrating differentially expressed genes for eac
See also Figure S2 and Tables S1, S2, and S3.hiPSC-CM Differentiation and Culture
All hiPSCs were derived with approval from the Institutional
Review Board at Stanford University. hiPSCs were cultured on Ma-
trigel-coated plates and differentiated into hiPSC-CMs using two-
dimensional monolayer differentiation (Burridge et al., 2014).Custom Spaceflight Hardware (BioServe Space
Technologies)
Plate Habitat
The Plate Habitat (PHAB) is an aluminumbox that can be sealed or
vented. When transporting live mammalian cells to the ISS, the
PHAB is charged with 5% CO2. Vents are then sealed with a cover
made of aluminum and Kapton tape. The PHAB, in this configura-
tion, can maintain 4.5%–5% CO2 for up to 9 days once charged
and sealed. On board the ISS, the vent cover is removed and the
PHAB is placed in an on-board incubator (SABL) that provides
37C and active 5%CO2 control. The PHAB provides containment
for liquids as per NASA safety protocol.
BioCell
The BioCell is a fully contained cell culture vessel for ISS use. The
6-well BioCell has an aluminum frame and a polysulfone center
with 6 individual wells, eachwith its own access port. A gas-perme-
able membrane covers both sides of the well. The membrane also
provides the growth surface for cells being cultured within each
well. Eachwell has amaximumvolume of 2.5mL. Fluid exchanges
are completed by attaching a syringe to each access port and then
exchanging the fluid in the well with the fluid in the syringe.
Space Automated Bioproduct Laboratory
TheSABL is a ‘‘smart’’ incubator currently aboard the ISS that canhold
temperatures between 5C and 43C. For mammalian cell culture,
BioServe’s Atmosphere Control Module (ACM) is inserted into SABL
and provides 5% CO2. For this hiPSC-CM experiment, the SABL
with ACM installed was used to house three PHABs, each with a 6-
well BioCell. Temperature set points for SABL are controlled from
the ground via BioServe’s PayloadOperations andCommandCenter.ACCESSION NUMBERS
RNA-sequencing data for this article are available on the Gene
Expression Omnibus with accession number GEO: GSE137081.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.10.006.flight
r after 4.5 weeks in microgravity, post-flight samples preserved
ntrol samples preserved at the same time as post-flight samples.
the three groups with p% 0.05.
action, (C) hypertrophy, and (D) metabolism, with *p% 0.05.
nrichment scoreR2 for at least one group) determined using the
ID) for genes differentially expressed between the indicated groups
h comparison with p% 0.05 based on a two-tailed Student’s t test.
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